Everolimus (everolimus)
(Everolimus)Mylan Pharmaceuticals Inc.
Usage: Everolimus is indicated for the treatment of Tuberous Sclerosis Complex (TSC) in patients aged 1 year and older for SEGA requiring intervention that cannot be curatively resected, and as adjunctive therapy for TSC-associated partial-onset seizures in patients aged 2 years and older.